3 Years Ago
1 Min Read
NARI down -7%. A closer look at what's happening:
Inari Medical, Inc. (NARI) is trading -7% lower at $75.64 today.
- Q2 net loss of -$10.19M, versus a net income of $4.07M in the prior year period
- CEO Hoffman departing effective January 1st 2023 due to "personal reasons." COO Drew Hykes will be new CEO
Inari Medical, Inc. has been trading between a 52-week high of $100 and a 52-week low of $50.5. The stock has a market cap of $4.02 Billion.
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs.
Headlines
Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha 08-03-22
Inari Medical, Inc. (NARI) Q2 2022 Earnings Call Transcript
The Motley Fool 08-03-22
Inari Medical stock falls as Q2 sees net loss; COO to helm company next year
Seeking Alpha 08-03-22
Inari Medical names Drew Hykes as CEO (NASDAQ:NARI)
Seeking Alpha 08-03-22
Inari Medical GAAP EPS of -$0.19 beats by $0.04, revenue of $92.7M beats by $4.9M
Seeking Alpha 08-03-22
Recommended Articles
